Skip to main content
. 2023 Nov 15;33(9):387–392. doi: 10.1089/cap.2023.0038

Table 1.

Cohort Summary

Subject ID Gender Age Marital status of parents Days in the study Hours watch worn during day Watch wear time (% per day) Number of disruptive events Diagnosis Medications at discharge
1 F 9 Separated 15 151.5 87 12a ODDb, ADHD Amphetamine/dextroamphetamine salts, clonidine
2 M 10 Separated 6 123.5 95 4 ODDb, ADHD, Developmental Speech Language Disorder Aripiprazole, atomoxetine, clonidine, divalproex sodium, fluoxetine
3 M 8 Married 10 166.6 87 1 ODDb, ADHD Methylphenidate, sertraline, melatonin
4 F 9 Unknown 6 102.4 83 2 ODDb, RAD, ADHD Guanfacine, methylphenidate, quetiapine, melatonin, iron, carbonyl-vitamin C
5 F 8 Separated 8 139.6 93 4 ODDb, ADHD, OCD Amphetamine/dextroamphetamine salts, escitalopram
6 M 7 Separated 4 55.9 90 0 ODDb, ADHD Clonidine, quetiapine, cholecalciferol
7 M 7 Single 5 83.5 86 0 Problem behavioral childb, Anxiety disorder unspecified Fluoxetine, multivitamin
8 M 9 Married 17 356.2 91 17a Conduct disorderb, ADHD, PTSD Lurasidone, methylphenidate
9 F 9 Single 7 87.6 96 3 Adjustment Disorder Mixed Emotion and Conductb, Anxiety Melatonin
10 F 7 Single 5 102.6 97 0 Disruptive Behavior Disorderb, PTSD, Developmental Speech Language Disorder Clonidine, risperidone
a

Disruptive behavior events in subjects who warranted physical restraint and used in training the decision tree.

b

Primary diagnosis is in bold. ODD, oppositional defiant disorder; ADHD, attention deficit/hyperactivity disorder; RAD, reactive attachment disorder; OCD, obsessive compulsive disorder; PTSD, posttraumatic stress disorder.